Clinical Trial Update: Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition [Phase 3]

View source ↗

Summary

Phase 3 trial investigating GLP-1 metabolism with acute neprilysin inhibition is currently suspended. The study targets adults with type 2 diabetes mellitus, pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Prediabetes
• Type 2 Diabetes Mellitus

Snippet

Sponsor: University of Pennsylvania | Conditions: Diabetes Mellitus, Type 2, Pre-diabetic | Phase 3 | Status: SUSPENDED